Molina Healthcare Downgraded to “Neutral” at Zacks (MOH)
Molina Healthcare (NYSE:MOH) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research note issued to investors on Friday. They currently have a $45.00 target price on the stock. Zacks‘s price target would suggest a potential upside of 4.21% from the stock’s previous close.
Shares of Molina Healthcare (NYSE:MOH) traded up 1.37% on Friday, hitting $43.77. 803,949 shares of the company’s stock traded hands. Molina Healthcare has a one year low of $31.10 and a one year high of $47.22. The stock’s 50-day moving average is $43.43 and its 200-day moving average is $40.26. The company has a market cap of $2.036 billion and a P/E ratio of 193.63.
Molina Healthcare (NYSE:MOH) last announced its earnings results on Wednesday, July 30th. The company reported $0.16 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.46 by $0.30. The company had revenue of $2.31 billion for the quarter, compared to the consensus estimate of $2.34 billion. During the same quarter in the prior year, the company posted $0.34 earnings per share. The company’s quarterly revenue was up 44.0% on a year-over-year basis. On average, analysts predict that Molina Healthcare will post $1.94 earnings per share for the current fiscal year.
A number of other firms have also recently commented on MOH. Analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Molina Healthcare in a research note on Wednesday, August 6th. They now have a $40.00 price target on the stock, up previously from $35.00. Separately, analysts at Cantor Fitzgerald reiterated a “hold” rating on shares of Molina Healthcare in a research note on Friday, August 1st. They now have a $40.00 price target on the stock, up previously from $35.00. Finally, analysts at Jefferies Group reiterated a “buy” rating on shares of Molina Healthcare in a research note on Friday, August 1st. They now have a $50.00 price target on the stock, down previously from $54.00. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $47.25.
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of families and individuals and to assist state agencies in their administration of the Medicaid program.
To view Zacks’ full report, visit Zacks’ official website.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.